VC  Tullis Health Investors

http://www.tullisfunds.com





     Office Locations:

11770 U.S. Highway 1, Suite 503
Palm Beach Gardens, FL 33408
Phone: 561-200-3300

 

Stages:

  • Early
  • Expansion
  • Growth
  • Seed


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Tullis Health Investors is a family of funds, each focused exclusively on healthcare. The family of funds is comprised of Tullis-Dickerson Capital Focus, and Tullis Opportunity Funds. Tullis was founded in 1986 and has raised four health care venture capital funds totaling approximately $400 million. The firm provides seed through late stage capital focusing on several segments: biotechnology and life sciences; pharmaceuticals; health care services; healthcare infrastructure & distribution; healthcare information technology; and medical devices. The Tullis Opportunity Funds invests in late-stage health care deals where liquidity may be foreseen within approximately a two to four-year horizon. The Tullis-Dickerson Capital Focus funds invests in healthcare companies at all stages of growth.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Barbara Bierer Venture Partner
    Darlene Franze VP for Admin
    David Leffell Venture Partner
    Jim Tullis Founder and Managing Principal
    John Tullis President

     

    Portfolio companies include:


      Adams Respiratory Therapeutics
        web link


      Adiana
        web link


      Aldagen
        web link


      Atritech
        web link


      BioBehavioral Diagnostics Company
        web link


      Biorexis Pharmaceutical
        web link


      CareSync
        web link


      Coherex Medical
        web link


      Estech
        web link


      Genoptix
        web link


      Ikano Therapeutics
        web link


      Impulse Monitoring
        web link


      LivHOME
        web link


      NovaVision
        web link


      Physician Sales & Service
        web link


      QuadraMed
        web link


      ReVision Therapeutics
        web link


      Sirion Therapeutics
        web link


      SupplyPro
        web link


      Synageva BioPharma
        web link


      TransMolecular
        web link


      ViaCell
        web link


      Vidacare Corporation
        web link


      Vital Access
        web link


     

    Recent News: